Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its
November 14, 2025
Italy busts €300 million streaming piracy ring
UBS Global Wealth Management lifts S&P 500 target on strong consumer spending, AI demand
German Ifo business sentiment unexpectedly rises
Hyundai to recall over 421,000 US vehicles over software brake issue, NHTSA says
Puig shares fall after collapse of Estée Lauder merger talks
China foreign minister to chair UN Security Council meeting in US, visit Canada